TSE:4507Pharmaceuticals
Shionogi (TSE:4507) Looks Cheap After FDA Accepts Cefiderocol Pediatric sNDA
Why the FDA sNDA for cefiderocol matters for Shionogi stock
The FDA sNDA acceptance for Shionogi (TSE:4507) antibiotic cefiderocol in pediatric hospital and urinary infections highlights a fresh regulatory milestone that could influence how investors think about the company s long term revenue mix.
See our latest analysis for Shionogi.
Investors have seen Shionogi s share price gain 3.45% over the past month, even after a roughly 10.49% decline over 90 days. At the same time, the 1 year total...